pyrrolidonecarboxylic acid has been researched along with Fatty Liver, Nonalcoholic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Q; Huang, S; Huo, Q; Li, P; Li, Q; Qi, S; Xia, J; Xie, N; Xu, D | 1 |
| Halmos, T; Suba, I | 1 |
1 review(s) available for pyrrolidonecarboxylic acid and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
[Role of the brain in the regulation of metabolism and energy expenditure: the central role of insulin, and insulin resistance of the brain].
Topics: Animals; Appetite Depressants; Appetite Regulation; Blood Glucose; Brain; Ceramides; Cognition; Diabetes Mellitus, Type 2; Energy Metabolism; Fatty Liver; Glucagon-Like Peptide 1; Humans; Hypothalamus; Incretins; Insulin; Insulin Resistance; Intracellular Signaling Peptides and Proteins; Metabolic Syndrome; Neuropeptides; Non-alcoholic Fatty Liver Disease; Oligopeptides; Orexins; Pyrrolidonecarboxylic Acid | 2011 |
1 other study(ies) available for pyrrolidonecarboxylic acid and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
Metabonomics screening of serum identifies pyroglutamate as a diagnostic biomarker for nonalcoholic steatohepatitis.
Topics: Biomarkers; Female; Humans; Male; Metabolomics; Middle Aged; Non-alcoholic Fatty Liver Disease; Pyrrolidonecarboxylic Acid | 2017 |